These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse. Paoni NF; Feldman MW; Gutierrez LS; Ploplis VA; Castellino FJ Physiol Genomics; 2003 Nov; 15(3):228-35. PubMed ID: 13130079 [TBL] [Abstract][Full Text] [Related]
23. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms. Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720 [TBL] [Abstract][Full Text] [Related]
24. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers. Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529 [TBL] [Abstract][Full Text] [Related]
25. EphB receptor activity suppresses colorectal cancer progression. Batlle E; Bacani J; Begthel H; Jonkheer S; Gregorieff A; van de Born M; Malats N; Sancho E; Boon E; Pawson T; Gallinger S; Pals S; Clevers H Nature; 2005 Jun; 435(7045):1126-30. PubMed ID: 15973414 [TBL] [Abstract][Full Text] [Related]
26. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Crawford HC; Fingleton BM; Rudolph-Owen LA; Goss KJ; Rubinfeld B; Polakis P; Matrisian LM Oncogene; 1999 May; 18(18):2883-91. PubMed ID: 10362259 [TBL] [Abstract][Full Text] [Related]
27. Hepatocyte nuclear factor-4alpha promotes gut neoplasia in mice and protects against the production of reactive oxygen species. Darsigny M; Babeu JP; Seidman EG; Gendron FP; Levy E; Carrier J; Perreault N; Boudreau F Cancer Res; 2010 Nov; 70(22):9423-33. PubMed ID: 21062980 [TBL] [Abstract][Full Text] [Related]
28. Increased expression of the thyroid hormone nuclear receptor TRα1 characterizes intestinal tumors with high Wnt activity. Uchuya-Castillo J; Aznar N; Frau C; Martinez P; Le Nevé C; Marisa L; Penalva LOF; Laurent-Puig P; Puisieux A; Scoazec JY; Samarut J; Ansieau S; Plateroti M Oncotarget; 2018 Jul; 9(57):30979-30996. PubMed ID: 30123421 [TBL] [Abstract][Full Text] [Related]
29. Dietary-induced ERbeta upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice. Barone M; Tanzi S; Lofano K; Scavo MP; Pricci M; Demarinis L; Papagni S; Guido R; Maiorano E; Ingravallo G; Comelli MC; Francavilla A; Di Leo A Carcinogenesis; 2010 Feb; 31(2):269-74. PubMed ID: 19945967 [TBL] [Abstract][Full Text] [Related]
30. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis. Hollmann CA; Kittrell FS; Medina D; Butel JS Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642 [TBL] [Abstract][Full Text] [Related]
31. Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells. Aoki K; Aoki M; Sugai M; Harada N; Miyoshi H; Tsukamoto T; Mizoshita T; Tatematsu M; Seno H; Chiba T; Oshima M; Hsieh CL; Taketo MM Oncogene; 2007 May; 26(24):3511-20. PubMed ID: 17160019 [TBL] [Abstract][Full Text] [Related]
32. [Expression and significance of APC, beta-catenin, C-myc, and Cyclin D1 proteins in colorectal carcinoma]. Dai WB; Ren ZP; Chen WL; DU J; Shi Z; Tang DY Ai Zheng; 2007 Sep; 26(9):963-6. PubMed ID: 17927853 [TBL] [Abstract][Full Text] [Related]
33. Foxf2 in intestinal fibroblasts reduces numbers of Lgr5(+) stem cells and adenoma formation by inhibiting Wnt signaling. Nik AM; Reyahi A; Pontén F; Carlsson P Gastroenterology; 2013 May; 144(5):1001-11. PubMed ID: 23376422 [TBL] [Abstract][Full Text] [Related]
34. Intestinal tumor progression is promoted by decreased apoptosis and dysregulated Wnt signaling in Ceacam1-/- mice. Leung N; Turbide C; Balachandra B; Marcus V; Beauchemin N Oncogene; 2008 Aug; 27(36):4943-53. PubMed ID: 18454175 [TBL] [Abstract][Full Text] [Related]
35. Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development. Nateri AS; Spencer-Dene B; Behrens A Nature; 2005 Sep; 437(7056):281-5. PubMed ID: 16007074 [TBL] [Abstract][Full Text] [Related]
36. RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis. Ito K; Lim AC; Salto-Tellez M; Motoda L; Osato M; Chuang LS; Lee CW; Voon DC; Koo JK; Wang H; Fukamachi H; Ito Y Cancer Cell; 2008 Sep; 14(3):226-37. PubMed ID: 18772112 [TBL] [Abstract][Full Text] [Related]
37. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes. Pendás-Franco N; Aguilera O; Pereira F; González-Sancho JM; Muñoz A Anticancer Res; 2008; 28(5A):2613-23. PubMed ID: 19035286 [TBL] [Abstract][Full Text] [Related]
38. Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Fodde R; Brabletz T Curr Opin Cell Biol; 2007 Apr; 19(2):150-8. PubMed ID: 17306971 [TBL] [Abstract][Full Text] [Related]
39. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice. Sieber OM; Howarth KM; Thirlwell C; Rowan A; Mandir N; Goodlad RA; Gilkar A; Spencer-Dene B; Stamp G; Johnson V; Silver A; Yang H; Miller JH; Ilyas M; Tomlinson IP Cancer Res; 2004 Dec; 64(24):8876-81. PubMed ID: 15604247 [TBL] [Abstract][Full Text] [Related]
40. The orphan receptor TR3 suppresses intestinal tumorigenesis in mice by downregulating Wnt signalling. Chen HZ; Liu QF; Li L; Wang WJ; Yao LM; Yang M; Liu B; Chen W; Zhan YY; Zhang MQ; Cai JC; Zheng ZH; Lin SC; Li BA; Wu Q Gut; 2012 May; 61(5):714-24. PubMed ID: 21873734 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]